Slow-release lanreotide in Graves’ ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial.

Chang, T.C.T.C.ChangLiao, S.L.S.L.Liao2011-02-142018-07-122011-02-142018-07-122006-05http://ntur.lib.ntu.edu.tw//handle/246246/225122en-USSlow-release lanreotide in Graves’ ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial.